Protein Assays Market By Product Type, By Technology, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

Description

List of Tables

According to a new report published by Allied Market Research, titled, "Protein Assays Market," The protein assays market was valued at $2.4 billion in 2022, and is estimated to reach $4.5 billion by 2032, growing at a CAGR of 6.5% from 2023 to 2032. Protein assays is one of the most used techniques in life science research. Protein purification, electrophoresis, cell biology, molecular biology, and other scientific applications require the estimation of protein concentration. Although there are a wide variety of protein assays available, none of the assays can be used without first considering their suitability for the application in drug discovery and disease diagnosis. Each assay has its own advantages and limitations and often it is necessary to obtain more than one type of protein assay for research applications.

The purpose of protein assay is to determine the amount or concentration of a specific protein or an array of different proteins in a sample. Isolating and detecting protein is used for many clinical and research processes. This can be a primary step before further manipulation in a research and development process, an initial capture of protein before structural analysis, or it can be a final detection step in a clinical laboratory as part of a disease diagnosis.

The determination of protein concentrations provides information about the necessity of corresponding intermediate steps. Protein quantitation could either be required for the total protein content of a sample, or for purified subsets thereof, such as affinity column fractions. There are various methods for protein assays such as dye binding protein assays (Bradford), protein assays based on copper ions (Lowry), or a novel test strip and spot application assay.

Major factors that drive the growth of the global protein assays market include rise in prevalence of chronic disease, upsurge in demand for personalized medicine, and critical role of protein assay method in drug discovery and development. Furthermore, increase in R&D investment in pharmaceutical & biotechnology industries for the development of technologically advanced protein assay kits and reagents and instruments and increase in the number of research activities in the field of proteomics are the major factors that increase the demand for protein assays tests kits and instruments and hence propel the growth of the market. In addition, increase in number of key market players and strategies they adopt for the development of technologically advanced protein assays products are the major factors that boost the growth of the protein assays market. For instance, in May 2023, 10x Genomics, Inc. a leader in single cell and spatial biology, announced the commercial availability of a new Visium CytAssist gene and protein expression product to expand the breadth of the Visium CytAssist spatial analysis capabilities. Visium CytAssist gene and protein expression enables researchers to simultaneously produce highly multiplexed protein and whole transcriptome RNA data mapped together from the same formalin-fixed, paraffin-embedded (FFPE) tissue section at high spatial resolution.

However, the lack of skilled workers and prohibitive cost associated with protein assay restrain the growth of the protein assays market. On the contrary, surge in demand for personalized medicine and expansion in the use of drug proteins are expected to provide lucrative opportunities for the growth of the protein assays market during the forecast period.

The protein assays market is segmented into product type, technology, application, end user, and region. Based on product type, the market is bifurcated into kits & reagents and instruments and accessories. Based on technology, it is divided into absorbance-based protein assay, colorimetric based protein assay and fluorescence-based protein assays. Based on application, it is classified into drug discovery and development and disease diagnosis. Based on end user, it is divided into pharmaceutical and biotechnology companies, clinical laboratories, and others. On the basis of region, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major players profiled in the report are Sartorius AG, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Perkin Elmer Inc., Meril Life Sciences Pvt. Ltd., Abcam PLC, Cell Signaling Technology, Merck KGaA, Bio-Rad Laboratories Inc, and Bio-Techne. The key players such as Sartorius AG and Abcam PLC have adopted product launch, acquisition, and partnership as major developmental strategies to improve the product portfolio.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the protein assays market analysis from 2022 to 2032 to identify the prevailing protein assays market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the protein assays market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global protein assays market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Market share analysis of players by products/segments
New Product Development/ Product Matrix of Key Players
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Average Selling Price Analysis / Price Point Analysis
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By Application

Drug Discovery and Development
Disease Diagnosis

By Product Type

Kits and Reagents
Instruments and Accessories

By Technology

Absorbance Based Protein Assays
Colorimetric based protein assay
Fluorescence-Based Protein Assays

By End User

Pharmaceutical and biotechnology companies
Clinical Laboratories
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

Agilent Technologies, Inc.
Perkin Elmer Inc
Abcam Plc
Meril Life Sciences Pvt. Ltd.
Cell Signaling Technology
Sartorius AG
Thermo Fisher Scientific Inc.
Merck KGaA
Bio-Rad Laboratories, Inc.
Bio-Techne

Product Code: A06187

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Low bargaining power of suppliers
- 3.3.2. Low threat of new entrants
- 3.3.3. Low threat of substitutes
- 3.3.4. Low intensity of rivalry
- 3.3.5. Low bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Increase in funding for R&D activities
  - 3.4.1.2. Rise in prevalence of chronic disease
- 3.4.2. Restraints
  - 3.4.2.1. High cost associated with protein assays
- 3.4.3. Opportunities
  - 3.4.3.1. Expansion in the use of drug protein

CHAPTER 4: PROTEIN ASSAYS MARKET, BY PRODUCT TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Kits and Reagents
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Instruments and Accessories
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country

CHAPTER 5: PROTEIN ASSAYS MARKET, BY TECHNOLOGY

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Absorbance Based Protein Assays
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Colorimetric based protein assay
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Fluorescence-Based Protein Assays
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country

CHAPTER 6: PROTEIN ASSAYS MARKET, BY APPLICATION

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Drug Discovery and Development
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Disease Diagnosis
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country

CHAPTER 7: PROTEIN ASSAYS MARKET, BY END USER

7.1. Overview
- 7.1.1. Market size and forecast
7.2. Pharmaceutical and biotechnology companies
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
7.3. Clinical Laboratories
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
7.4. Others
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country

CHAPTER 8: PROTEIN ASSAYS MARKET, BY REGION

8.1. Overview
- 8.1.1. Market size and forecast By Region
8.2. North America
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by Product Type
- 8.2.3. Market size and forecast, by Technology
- 8.2.4. Market size and forecast, by Application
- 8.2.5. Market size and forecast, by End User
- 8.2.6. Market size and forecast, by country
  - 8.2.6.1. U.S.
  - 8.2.6.1.1. Market size and forecast, by Product Type
  - 8.2.6.1.2. Market size and forecast, by Technology
  - 8.2.6.1.3. Market size and forecast, by Application
  - 8.2.6.1.4. Market size and forecast, by End User
  - 8.2.6.2. Canada
  - 8.2.6.2.1. Market size and forecast, by Product Type
  - 8.2.6.2.2. Market size and forecast, by Technology
  - 8.2.6.2.3. Market size and forecast, by Application
  - 8.2.6.2.4. Market size and forecast, by End User
  - 8.2.6.3. Mexico
  - 8.2.6.3.1. Market size and forecast, by Product Type
  - 8.2.6.3.2. Market size and forecast, by Technology
  - 8.2.6.3.3. Market size and forecast, by Application
  - 8.2.6.3.4. Market size and forecast, by End User
8.3. Europe
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by Product Type
- 8.3.3. Market size and forecast, by Technology
- 8.3.4. Market size and forecast, by Application
- 8.3.5. Market size and forecast, by End User
- 8.3.6. Market size and forecast, by country
  - 8.3.6.1. Germany
  - 8.3.6.1.1. Market size and forecast, by Product Type
  - 8.3.6.1.2. Market size and forecast, by Technology
  - 8.3.6.1.3. Market size and forecast, by Application
  - 8.3.6.1.4. Market size and forecast, by End User
  - 8.3.6.2. France
  - 8.3.6.2.1. Market size and forecast, by Product Type
  - 8.3.6.2.2. Market size and forecast, by Technology
  - 8.3.6.2.3. Market size and forecast, by Application
  - 8.3.6.2.4. Market size and forecast, by End User
  - 8.3.6.3. UK
  - 8.3.6.3.1. Market size and forecast, by Product Type
  - 8.3.6.3.2. Market size and forecast, by Technology
  - 8.3.6.3.3. Market size and forecast, by Application
  - 8.3.6.3.4. Market size and forecast, by End User
  - 8.3.6.4. Italy
  - 8.3.6.4.1. Market size and forecast, by Product Type
  - 8.3.6.4.2. Market size and forecast, by Technology
  - 8.3.6.4.3. Market size and forecast, by Application
  - 8.3.6.4.4. Market size and forecast, by End User
  - 8.3.6.5. Spain
  - 8.3.6.5.1. Market size and forecast, by Product Type
  - 8.3.6.5.2. Market size and forecast, by Technology
  - 8.3.6.5.3. Market size and forecast, by Application
  - 8.3.6.5.4. Market size and forecast, by End User
  - 8.3.6.6. Rest of Europe
  - 8.3.6.6.1. Market size and forecast, by Product Type
  - 8.3.6.6.2. Market size and forecast, by Technology
  - 8.3.6.6.3. Market size and forecast, by Application
  - 8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
- 8.4.1. Key market trends, growth factors and opportunities
- 8.4.2. Market size and forecast, by Product Type
- 8.4.3. Market size and forecast, by Technology
- 8.4.4. Market size and forecast, by Application
- 8.4.5. Market size and forecast, by End User
- 8.4.6. Market size and forecast, by country
  - 8.4.6.1. Japan
  - 8.4.6.1.1. Market size and forecast, by Product Type
  - 8.4.6.1.2. Market size and forecast, by Technology
  - 8.4.6.1.3. Market size and forecast, by Application
  - 8.4.6.1.4. Market size and forecast, by End User
  - 8.4.6.2. China
  - 8.4.6.2.1. Market size and forecast, by Product Type
  - 8.4.6.2.2. Market size and forecast, by Technology
  - 8.4.6.2.3. Market size and forecast, by Application
  - 8.4.6.2.4. Market size and forecast, by End User
  - 8.4.6.3. Australia
  - 8.4.6.3.1. Market size and forecast, by Product Type
  - 8.4.6.3.2. Market size and forecast, by Technology
  - 8.4.6.3.3. Market size and forecast, by Application
  - 8.4.6.3.4. Market size and forecast, by End User
  - 8.4.6.4. India
  - 8.4.6.4.1. Market size and forecast, by Product Type
  - 8.4.6.4.2. Market size and forecast, by Technology
  - 8.4.6.4.3. Market size and forecast, by Application
  - 8.4.6.4.4. Market size and forecast, by End User
  - 8.4.6.5. South Korea
  - 8.4.6.5.1. Market size and forecast, by Product Type
  - 8.4.6.5.2. Market size and forecast, by Technology
  - 8.4.6.5.3. Market size and forecast, by Application
  - 8.4.6.5.4. Market size and forecast, by End User
  - 8.4.6.6. Rest of Asia-Pacific
  - 8.4.6.6.1. Market size and forecast, by Product Type
  - 8.4.6.6.2. Market size and forecast, by Technology
  - 8.4.6.6.3. Market size and forecast, by Application
  - 8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
- 8.5.1. Key market trends, growth factors and opportunities
- 8.5.2. Market size and forecast, by Product Type
- 8.5.3. Market size and forecast, by Technology
- 8.5.4. Market size and forecast, by Application
- 8.5.5. Market size and forecast, by End User
- 8.5.6. Market size and forecast, by country
  - 8.5.6.1. Brazil
  - 8.5.6.1.1. Market size and forecast, by Product Type
  - 8.5.6.1.2. Market size and forecast, by Technology
  - 8.5.6.1.3. Market size and forecast, by Application
  - 8.5.6.1.4. Market size and forecast, by End User
  - 8.5.6.2. Saudi Arabia
  - 8.5.6.2.1. Market size and forecast, by Product Type
  - 8.5.6.2.2. Market size and forecast, by Technology
  - 8.5.6.2.3. Market size and forecast, by Application
  - 8.5.6.2.4. Market size and forecast, by End User
  - 8.5.6.3. South Africa
  - 8.5.6.3.1. Market size and forecast, by Product Type
  - 8.5.6.3.2. Market size and forecast, by Technology
  - 8.5.6.3.3. Market size and forecast, by Application
  - 8.5.6.3.4. Market size and forecast, by End User
  - 8.5.6.4. Rest of LAMEA
  - 8.5.6.4.1. Market size and forecast, by Product Type
  - 8.5.6.4.2. Market size and forecast, by Technology
  - 8.5.6.4.3. Market size and forecast, by Application
  - 8.5.6.4.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

10.1. Sartorius AG
- 10.1.1. Company overview
- 10.1.2. Key executives
- 10.1.3. Company snapshot
- 10.1.4. Operating business segments
- 10.1.5. Product portfolio
- 10.1.6. Business performance
- 10.1.7. Key strategic moves and developments
10.2. Agilent Technologies, Inc.
- 10.2.1. Company overview
- 10.2.2. Key executives
- 10.2.3. Company snapshot
- 10.2.4. Operating business segments
- 10.2.5. Product portfolio
- 10.2.6. Business performance
10.3. Thermo Fisher Scientific Inc.
- 10.3.1. Company overview
- 10.3.2. Key executives
- 10.3.3. Company snapshot
- 10.3.4. Operating business segments
- 10.3.5. Product portfolio
- 10.3.6. Business performance
10.4. Perkin Elmer Inc
- 10.4.1. Company overview
- 10.4.2. Key executives
- 10.4.3. Company snapshot
- 10.4.4. Operating business segments
- 10.4.5. Product portfolio
- 10.4.6. Business performance
10.5. Meril Life Sciences Pvt. Ltd.
- 10.5.1. Company overview
- 10.5.2. Key executives
- 10.5.3. Company snapshot
- 10.5.4. Operating business segments
- 10.5.5. Product portfolio
10.6. Cell Signaling Technology
- 10.6.1. Company overview
- 10.6.2. Key executives
- 10.6.3. Company snapshot
- 10.6.4. Operating business segments
- 10.6.5. Product portfolio
10.7. Abcam Plc
- 10.7.1. Company overview
- 10.7.2. Key executives
- 10.7.3. Company snapshot
- 10.7.4. Operating business segments
- 10.7.5. Product portfolio
- 10.7.6. Business performance
- 10.7.7. Key strategic moves and developments
10.8. Merck KGaA
- 10.8.1. Company overview
- 10.8.2. Key executives
- 10.8.3. Company snapshot
- 10.8.4. Operating business segments
- 10.8.5. Product portfolio
- 10.8.6. Business performance
10.9. Bio-Rad Laboratories, Inc.
- 10.9.1. Company overview
- 10.9.2. Key executives
- 10.9.3. Company snapshot
- 10.9.4. Operating business segments
- 10.9.5. Product portfolio
- 10.9.6. Business performance
10.10. Bio-Techne
- 10.10.1. Company overview
- 10.10.2. Key executives
- 10.10.3. Company snapshot
- 10.10.4. Operating business segments
- 10.10.5. Product portfolio
- 10.10.6. Business performance